ConMed, a surgical device maker, has asked its financial advisers — Bank of America, Merrill Lynch and Greenhill & Co — to contact orthopedic device makers about a possible sale.
The company has been under pressure from activist investors since last year, who took issue with the company’s performance and corporate governance. It has roughly 3,600 employees and a direct selling presence in 16 countries outside the United States. It creates devices for a number of specialties, including orthopedics and sports medicine, gynecology, neurosurgery and gastroenterology, according to the report.
More Articles on Devices:
Mazor Robotics 2013 Net Loss Shoots to $20M
Advancement in Lateral Spine Technology: Q&A with Vertebral Technologies, Inc. CEO Dr. Jeffrey Felt
EDGE Orthopaedics Receives FDA 510(k) Clearance for BITE Compression Screws
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
